Citation Impact
60 standout
Citing Papers
Optimized inhaled LNP formulation for enhanced treatment of idiopathic pulmonary fibrosis via mRNA-mediated antibody therapy
2024 Standout
Editors’ Choice—Challenges and Opportunities for Developing Electrochemical Biosensors with Commercialization Potential in the Point-of-Care Diagnostics Market
2024 Standout
Works of Peter Reimnitz being referenced
Impact of infections on long-term outcome after severe middle cerebral artery infarction
2012
Ciprofloxacin dry powder for inhalation in non-cystic fibrosis bronchiectasis: a phase II randomised study
2012
Author Peers
| Author | PHEOH | Epidemiology | Clinical Biochemistry | PRM | Infectious Diseases | Last Decade | Papers | Cites |
|---|---|---|---|---|---|---|---|---|
| Peter Reimnitz | 118 | 321 | 57 | 231 | 123 | 26 | 872 | |
| O. B. Milder | 1 | 1 | 3 | 49 | 548 | |||
| Qing Chen | 34 | 26 | 1 | 4 | 3 | 17 | 379 | |
| Taiki Fuji | 29 | 264 | ||||||
| Janet M. Carey | 6 | 3 | 1 | 1 | 1 | 12 | 426 | |
| Susumu Fujisaku | 45 | 36 | 1 | 38 | 1 | 18 | 278 |
All Works
Loading papers...